glp 1 parkinson's The glucagon-like peptide (GLP) receptor as a therapeutic target in disease: mechanisms of action GLP-1R Agonists - Glucagon-Like Peptide

Neurological Fatigue: By reducing elevated ventricular lactate and supporting efficient mitochondrial ATP production in the brain, NAC helps alleviate the heavy, "weighted" feeling in the head often reported by patients

Improved HbA1c: GLP-1 drugs consistently reduce HbA1c an important long-term marker of diabetes control often by 11.5%, depending on the agent and dose

Circulating trimethylamine N-oxide in association with diet and cardiometabolic biomarkers: an international pooled analysis

Traditionally, patients gradually increase their dosage over time until they reach a maintenance dose established through clinical research